Clinical trial

A Double-Blind, Placebo Controlled Study of Intravenous Immunoglobulin for HIV-Associated Myelopathy

NCT01561755

StatusTERMINATED
Study typeINTERVENTIONAL
Start date2012-02-01
PhasePHASE4

Study timeline

Study start (unknown)2012-02-01Date precision: month
Registry last updated2018-04-13
Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.